These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24014944)

  • 1. Detection of alloimmunization to ensure safer transfusion practice.
    Sood R; Makroo RN; Riana V; Rosamma NL
    Asian J Transfus Sci; 2013 Jul; 7(2):135-9. PubMed ID: 24014944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients.
    Makarovska-Bojadzieva T; Velkova E; Blagoevska M
    Open Access Maced J Med Sci; 2017 Apr; 5(2):107-111. PubMed ID: 28507611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of red cell alloimmunization in multi transfused patients at a Tertiary care teaching hospital.
    Handa A; Kukar N; Maharishi RN; Syal N; Arora H
    J Family Med Prim Care; 2020 Jun; 9(6):2907-2911. PubMed ID: 32984147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and specificity of red blood cell alloimmunization in chilean transfused patients.
    Caamaño J; Musante E; Contreras M; Ulloa H; Reyes C; Inaipil V; Saavedra N; Guzmán N
    Transfus Med Hemother; 2015 Jan; 42(1):4-7. PubMed ID: 25960709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: a prospective study.
    Jain R; Choudhury N; Chudgar U; Harimoorthy V; Desai P; Perkins J; Johnson ST
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):291-6. PubMed ID: 25435730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of solid-phase red cell adherence and microcolumn agglutination technology using untreated and enzyme-treated red blood cells.
    Sanders DR
    Immunohematology; 2023 Dec; 39(4):166-171. PubMed ID: 38179782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.
    Pessoni LL; Ferreira MA; Silva JCRD; Alcântara KC
    Hematol Transfus Cell Ther; 2018; 40(4):326-331. PubMed ID: 30370410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell alloimmunization in repeatedly transfused patients.
    Bhuva DK; Vachhani JH
    Asian J Transfus Sci; 2017; 11(2):115-120. PubMed ID: 28970677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization in multi-transfused patients with chronic kidney disease in Port Harcourt, South-South Nigeria.
    Obi EI; Pughikumo CO; Oko-Jaja RI
    Afr Health Sci; 2018 Dec; 18(4):979-987. PubMed ID: 30766563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India.
    Makroo RN; Rajput S; Agarwal S; Chowdhry M; Prakash B; Karna P
    Asian J Transfus Sci; 2018; 12(1):17-20. PubMed ID: 29563670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red Cell Alloantibody Screening: Comparative Analysis of Three Different Technologies.
    Orlando N; Bianchi M; Valentini CG; Maresca M; Massini G; Putzulu R; Zini G; Teofili L
    Transfus Med Hemother; 2018 May; 45(3):179-183. PubMed ID: 29928173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBC alloimmunization and double alloantibodies in thalassemic patients.
    Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
    Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
    Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
    Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients.
    Dhawan HK; Kumawat V; Marwaha N; Sharma RR; Sachdev S; Bansal D; Marwaha RK; Arora S
    Asian J Transfus Sci; 2014 Jul; 8(2):84-8. PubMed ID: 25161344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Jk
    Kay B; Poisson JL; Tuma CW; Shulman IA
    Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis).
    Wong K; Lai WK; Jackson DE
    Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.
    Chaudhari CN
    Med J Armed Forces India; 2011 Jan; 67(1):34-7. PubMed ID: 27365758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.